Updated: Oct 24
November 08, 2022, at 2:30 pm EST, Hosted by AnHeart Therapeutics
On November 08, 2022, at 2:30 pm EST, AnHeart Therapeutics will host a one-hour webinar on available ROS1+ targeted therapies. Topics to be covered include:
The current treatment landscape for patients with ROS1+ NSCLC
Differences between ROS1 inhibitors either already approved or in development
How to improve outcomes for all ROS1+ cancers
The live webinar will include a 30-min presentation followed by a discussion involving ROS1 experts Dr. Ross Camidge (University of Colorado) and Dr Misako Nagasaka (UC Irving), with Janet Freeman-Daily of The ROS1ders as moderator.